外泌體診斷和治療市場按類型、產品/服務、來源、應用、最終用戶和地區分類

2025 年全球外泌體診斷和治療市場規模估計為 9,280 萬美元，預計到 2032 年將達到 3.084 億美元，2025 年至 2032 年的複合年成長率為 18.7%。

數字。外泌體診斷和治療市場佔有率（按地區分類）（2025年）

近年來，全球外泌體診斷和治療市場顯著成長。外泌體是奈米大小的細胞外囊泡，可作為蛋白質、脂質和核酸等生物分子的載體。它在細胞間通訊和免疫反應中發揮重要作用。外泌體在癌症、神經系統疾病和心血管疾病等各種疾病的診斷和治療中的應用日益廣泛，正在推動該市場的成長。研發和醫療保健產業參與者擴大挖掘外泌體的潛力，以開發微創液態切片、藥物輸送解決方案和再生療法。分離和表徵技術的進步進一步擴大了外泌體研究和臨床應用的範圍。

市場動態：

推動外泌體診斷和治療市場發展的關鍵因素是對非侵入性診斷方法的需求不斷成長、目標疾病的盛行率不斷上升、基於外泌體的療法相對於傳統藥物的優勢以及技術進步。然而，分離技術和表徵工具的高成本以及缺乏標準化限制了市場的成長。從積極的一面來看，改善的訪問和持續的改進正在創造新的機會。抗衰老藥物、不孕症治療和感染疾病預防的新應用也前景看好。

本研究的主要特點

本報告對全球外泌體診斷和治療市場進行了詳細分析，並以 2024 年為基準年，給出了預測期（2025-2032 年）的市場規模和年複合成長率（CAGR%）。

它強調了各個領域的潛在商機，並解釋了該市場的有吸引力的投資提案矩陣。

它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的重要見解。

全球外泌體診斷和治療市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。

研究涉及的主要企業包括 Evox Therapeutics Ltd、Exosome Diagnostics、Aethlon Medical、NanoSomix Inc、Thermo Fisher Scientific、Malvern Panalytical 和 System Biosciences LLC。

本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球外泌體診斷和治療市場報告涉及該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員可以透過用於分析全球外泌體診斷和治療市場的各種策略矩陣來促進他們的決策。

目錄

第1章 調查目的與前提條件

• 研究目標
• 先決條件
• 簡稱

第2章 市場展望

• 報告描述
  • 市場定義和範圍
• 執行摘要

第3章市場動態、法規與趨勢分析

• 市場動態
• 影響分析
• 主要亮點
• 監管情景
• 產品發布/核准
• PEST分析
• 波特分析
• 併購場景

4. 全球外泌體診斷與治療市場（按類型），2025-2032

• 外泌體診斷
• 外泌體治療

5. 2025-2032 年全球外泌體診斷和治療市場（按產品和服務分類）

• 設備和服務
• 套件和試劑

6. 全球外泌體診斷與治療市場（依來源分類），2025 年至 2032 年

• 幹細胞
• 血液和血漿
• 尿
• 其他來源

7. 全球外泌體診斷與治療市場（按應用分類），2025 年至 2032 年

• 癌症
• 皮膚病
• 肌肉骨骼疾病
• 心血管疾病
• 其他

8. 全球外泌體診斷與治療市場（依最終使用者分類），2025 年至 2032 年

• 醫院和診斷中心
• 診所和醫生環境
• 學術研究所
• 合約研究組織
• 其他

9. 2020-2032 年全球外泌體診斷與治療市場（按地區）

• 北美洲
• 美國
• 加拿大
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 歐洲
• 德國
• 英國
• 西班牙
• 法國
• 義大利
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 中國
• 印度
• 日本
• 澳洲
• 韓國
• ASEAN
• 其他亞太地區
• 中東
• 海灣合作理事會國家
• 以色列
• 其他中東地區
• 非洲
• 南非
• 北非
• 中部非洲

第10章 競爭格局

• Thermo Fisher Scientific
• NanoSomix
• NX Pharmagen
• Malvern Instruments
• Capricor Therapeutic
• Exosome Diagnostics
• Exiqon A/S
• System Biosciences
• Exosome Sciences
• Aegle Therapeutic
• AMS Biotechnology
• Miltenyi Biotec
• Codiak BioSciences Inc.
• Lonza Group（HansaBioMed Life Sciences Ltd.）
• AcouSort AB
• Aethlon Medical, Inc.
• AGC Biologics
• Anjarium Biosciences AG
• Aruna Bio
• Brexogen
• Capricor Therapeutics
• Cells for Cells
• Ciloa
• ConvEyXO

第 11 章分析師建議

• 命運之輪
• 分析師觀點
• 一致的機會圖

第12章參考文獻與調查方法

• 參考
• 調查方法
• 關於出版商

Global Exosomes Diagnostic and Therapeutic Market is estimated to be valued at USD 92.8 Mn in 2025 and is expected to reach USD 308.4 Mn by 2032, growing at a compound annual growth rate (CAGR) of 18.7% from 2025 to 2032.

Figure. Exosomes Diagnostic And Therapeutic Market Share (%), By Region 2025

The global exosomes diagnostic and therapeutic market has been witnessing significant growth in the recent years. Exosomes are nano-sized extracellular vesicles that act as carriers of biomolecules like proteins, lipids, and nucleic acids. They play an important role in cell-to-cell communication and immune response. The growing application of exosomes in diagnosis and treatment of various diseases like cancer, neurological disorders, and cardiovascular conditions is driving the growth of this market. Researchers and healthcare industry players are increasingly leveraging the potential of exosomes for developing minimally invasive liquid biopsies, drug delivery solutions, and regenerative therapies. Advancements in isolation and characterization techniques are further expanding the scope of research as well as clinical use of exosomes.

Market Dynamics:

The key drivers propelling the exosomes diagnostic and therapeutic market include growing demand for non-invasive diagnostic methods, increasing prevalence of target diseases, advantages of exosome-based therapies over conventional drugs, and technological advancements. However, high costs associated with isolation techniques and characterization tools, as well as lack of standardization are limiting the market growth. On the positive side, improved access and ongoing refinements are creating new opportunities. Emerging applications in anti-aging therapeutics, fertility management, and infection control also hold promise.

Key features of the study:

This report provides in-depth analysis of the global exosomes diagnostic and therapeutic market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global exosomes diagnostic and therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Evox Therapeutics Ltd, Exosome Diagnostics, Aethlon Medical, NanoSomix Inc, Thermo Fisher Scientific, Malvern Panalytical, System Biosciences LLC.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global exosomes diagnostic and therapeutic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global exosomes diagnostic and therapeutic market.

Detailed Segmentation:

• By Type Insights (Revenue, USD Mn, 2020 - 2032)
  • Exosome Diagnostics
  • Exosome Therapeutics
• By Product & Service Insights (Revenue, USD Mn, 2020 - 2032)
  • Instruments & Services
  • Kits & Reagents
• By Source Insights (Revenue, USD Mn, 2020 - 2032)
  • Stem Cells
  • Blood & Blood Plasma
  • Urine
  • Other Sources
• By Application Insights (Revenue, USD Mn, 2020 - 2032)
  • Cancer
  • Dermatological Diseases
  • Musculoskeletal Disorders
  • Cardiovascular Diseases
  • Others
• By End User Insights (Revenue, USD Mn, 2020 - 2032)
  • Hospitals & Diagnostic Centers
  • Clinics and Physician Settings
  • Academic and Research Institutions
  • Contract Research Organizations
  • Others
• By Regional Insights (Revenue, USD Mn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Thermo Fisher Scientific
  • NanoSomix
  • NX Pharmagen
  • Malvern Instruments
  • Capricor Therapeutic
  • Exosome Diagnostics
  • Exiqon A/S
  • System Biosciences
  • Exosome Sciences
  • Aegle Therapeutic
  • AMS Biotechnology
  • Miltenyi Biotec
  • Codiak BioSciences Inc.
  • Lonza Group (HansaBioMed Life Sciences Ltd.)
  • AcouSort AB
  • Aethlon Medical, Inc.
  • AGC Biologics
  • Anjarium Biosciences AG
  • Aruna Bio
  • Brexogen
  • Capricor Therapeutics
  • Cells for Cells
  • Ciloa
  • ConvEyXO

Table of Contents

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

• Research Objectives
• Assumptions
• Abbreviations

2. MARKET PURVIEW

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Exosomes Diagnostic and Therapeutic Market, By Type
  • Global Exosomes Diagnostic and Therapeutic Market, By Product & Service
  • Global Exosomes Diagnostic and Therapeutic Market, By Source
  • Global Exosomes Diagnostic and Therapeutic Market, By Application
  • Global Exosomes Diagnostic and Therapeutic Market, By End User
  • Global Exosomes Diagnostic and Therapeutic Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

• Market Dynamics
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Exosomes Diagnostic and Therapeutic Market, By Type, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Exosome Diagnostics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Exosome Therapeutics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

5. Global Exosomes Diagnostic and Therapeutic Market, By Product & Service, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Instruments & Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Kits & Reagents
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

6. Global Exosomes Diagnostic and Therapeutic Market, By Source, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Stem Cells
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Blood & Blood Plasma
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Urine
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Other Sources
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

7. Global Exosomes Diagnostic and Therapeutic Market, By Application, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cancer
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Dermatological Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Musculoskeletal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Cardiovascular Diseases
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

8. Global Exosomes Diagnostic and Therapeutic Market, By End User, 2025-2032, (USD Mn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals & Diagnostic Centers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Clinics and Physician Settings
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Contract Research Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)

9. Global Exosomes Diagnostic and Therapeutic Market, By Region, 2020 - 2032, Value (USD Mn)

• Introduction
  • Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
  • Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Mn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Product & Service, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Source, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Mn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Mn)
• South Africa
• North Africa
• Central Africa

10. COMPETITIVE LANDSCAPE

• Thermo Fisher Scientific
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• NanoSomix
• NX Pharmagen
• Malvern Instruments
• Capricor Therapeutic
• Exosome Diagnostics
• Exiqon A/S
• System Biosciences
• Exosome Sciences
• Aegle Therapeutic
• AMS Biotechnology
• Miltenyi Biotec
• Codiak BioSciences Inc.
• Lonza Group (HansaBioMed Life Sciences Ltd.)
• AcouSort AB
• Aethlon Medical, Inc.
• AGC Biologics
• Anjarium Biosciences AG
• Aruna Bio
• Brexogen
• Capricor Therapeutics
• Cells for Cells
• Ciloa
• ConvEyXO

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us